ARQT |
Arcutis Biotherapeutics, Inc. |
Aug 2, 2024 |
1 |
-$47.1K |
4 |
Aug 5, 2024 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
May 27, 2024 |
2 |
-$16K |
4 |
May 29, 2024 |
Reporting Person's title: SVP General Counsel and Corporate Secretary |
ARQT |
Arcutis Biotherapeutics, Inc. |
May 2, 2024 |
1 |
-$43.8K |
4 |
May 3, 2024 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Mar 4, 2024 |
1 |
-$41.8K |
4 |
Mar 6, 2024 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Feb 13, 2024 |
6 |
$0 |
4 |
Feb 15, 2024 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Jan 12, 2024 |
2 |
$0 |
4 |
Jan 17, 2024 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Nov 18, 2023 |
2 |
-$3.66K |
4 |
Nov 21, 2023 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
May 27, 2023 |
3 |
-$4.94K |
4 |
Jun 2, 2023 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Mar 2, 2023 |
4 |
-$22.7K |
4 |
Mar 6, 2023 |
Reporting Person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Nov 18, 2022 |
2 |
-$31.3K |
4 |
Nov 22, 2022 |
Reporting person's title: Senior Vice President and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
May 27, 2022 |
2 |
-$35.4K |
4 |
Jun 2, 2022 |
SVP and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Mar 3, 2022 |
2 |
$0 |
4 |
Mar 7, 2022 |
SVP and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Jan 3, 2022 |
1 |
$0 |
4 |
Jan 5, 2022 |
SVP and General Counsel |
ARQT |
Arcutis Biotherapeutics, Inc. |
Jan 3, 2022 |
0 |
$0 |
3 |
Jan 5, 2022 |
SVP and General Counsel |
HALO |
HALOZYME THERAPEUTICS, INC. |
Sep 4, 2021 |
3 |
-$144K |
4 |
Sep 7, 2021 |
SVP, General Counsel |